Company Overview of Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. develops small molecule drugs for the treatment of cancer deceases. The company’s products include oral inhibitors of the cancer-linked serine/threonine protein kinases (CK2 and Pim); and oral agents that activate p53 via modulation of RNA Polymerase I activity in the upstream ribosome biogenesis pathway. Cylene Pharmaceuticals, Inc. was formerly known as Cyternex, Inc. and changed its name in October 2003. The company was founded in 1997 and is based in San Diego, California.
5820 Nancy Ridge Drive
San Diego, CA 92121
Founded in 1997
Key Executives for Cylene Pharmaceuticals, Inc.
Similar Private Companies By Industry
|JR Scientific, Inc.||United States|
|PharmaPrint Inc.||United States|
|Centrexion Corp||United States|
|Medarex, L.L.C.||United States|
|International Immuno Diagnostics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Cylene Pharmaceuticals, Inc., please visit www.cylenepharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.